ArticleFrontiers in oncology2023

Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac.

Lin-Rui Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.